SCHEMBL3565216

SCHEMBL3565216

NCc1ccn(-c2ccoc2)c(=O)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RB1 P06400 1/20 0.43
CDK1 P06493 1/20 0.43
CDK4 P11802 1/20 0.43
CCNB1 P14635 1/20 0.43
CCND1 P24385 1/20 0.43
CDK2 P24941 1/20 0.43
CSNK2A1 P68400 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.34
LOXL2 Q9Y4K0 1/20 0.33
ALDH1A1 P00352 1/20 0.33
ALOX15 P16050 1/20 0.33
HTT P42858 1/20 0.33
ATM Q13315 1/20 0.33
CA12 O43570 1/20 0.32
CA1 P00915 1/20 0.32
CA2 P00918 1/20 0.32
CA3 P07451 1/20 0.32
CA4 P22748 1/20 0.32
CA6 P23280 1/20 0.32
CA5A P35218 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL3570138 0.98 RB1 (0.42) RB1CDK1CDK4CCNB1CCND1
Trifluoroacetic Acid SCHEMBL3570929 0.88 RB1 (0.39) RB1CDK1CDK4CCNB1CCND1
SCHEMBL3580054 0.77 SCD (0.41) RB1CDK1CDK4CCNB1CCND1
SCHEMBL3571776 0.76 SMN1; SMN2 (0.59) CDK1CDK4CCNB1CCND1CDK2
SCHEMBL3559620 0.75 RB1 (0.35) RB1CDK1CDK4CCNB1CCND1
SCHEMBL3569436 0.72 RB1 (0.36) RB1CDK1CDK4CCNB1CCND1
SCHEMBL3566493 0.71 HCAR1 (0.36) SMN1; SMN2ALDH1A1ALOX15HTTATM
SCHEMBL4754442 0.70
SCHEMBL1912334 0.68 LOXL2 (0.59) LOXL2PKM
SCHEMBL3572780 0.66 PIK3CD (0.36) LOXL2CA12CA1CA2CA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7713994-B2 Substituted isoquinoline-1,3(2H,4H)-diones, 1-thioxo,1,4-dihydro-2H-isoquinoline-3-ones and 1,4-dihyro-3 (2H)-isoquinolones and methods of use thereof WYETH LLC (US) 2010-05-11 US disclosed
US-20080085890-A1 Substituted isoquinoline-1,3(2H,4H)-diones, 1-thioxo-1,4-dihydro-2H-isoquinoline-3-ones and 1,4-dihydro-3 (2H)-isoquinolones and methods of use thereof WYETH (US) 2008-04-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080085890-A1 Substituted isoquinoline-1,3(2H,4H)-diones, 1-thioxo-1,4-dihydro-2H-isoquinoline-3-ones and 1,4-dihydro-3 (2H)-isoquinolones and methods of use thereof SULT1E1, RECQL, HAX1 RB1 1280/4885CDK1 661/4885CDK4 529/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.